Brief: Immunovia Q3 Pre-Tax Loss Widens To SEK 38.1 Mln
Nov 12 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* Q3 NET SALES SEK 37,000 VERSUS SEK 92,000 YEAR AGO
* Q3 PRE-TAX LOSS SEK 38.1 MILLION VERSUS LOSS SEK 25.6
MILLION
YEAR AGO
* IS AIMING TO START SALES AT END OF Q1, WITH SUBSEQUENT
COMMERCIAL DIAGNOSTICS DURING Q2
Source text: [ID:https://bit.ly/3nfeI5e]
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study